deCODE biostuctures Extension of Contract with CGI Pharmaceuticals
News Jun 13, 2007
deCODE successfully solved the co-crystal structure of a human kinase (whose structure had not previously been reported) in complex with lead inhibitors developed by CGI Pharmaceuticals, Inc.
In addition, deCODE and CGI have now extended their X-ray crystallography collaboration to further support the ongoing drug development efforts at CGI.
“The high-resolution structural information provided by deCODE biostructures has provided a clear path for CGI to progress its structure-guided drug development programs. We are delighted to have now extended our collaboration with deCODE.” said David Armistead, Chief Scientific Officer of CGI.
“Under the extended agreement, deCODE biostructures is excited to continue supporting CGI through our gene to structure collaborative research on an exclusive kinase target.” remarked Lance Stewart, President of deCODE biostructures, Inc.
The research fee and milestone-based collaboration provides CGI with access to the expertise of deCODE biostructures in protein-ligand co-structure determination, from the engineering of synthetic kinase genes to the determination of high resolution kinase-ligand co-crystal structures. Financial details of the collaboration were not released.
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
The DNA Shuffle: Barcoding Trick is Boost to RNA-SeqNews
SPLiT-seq is a new technology that can separate thousands of cells using innovative barcoding technology.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018